<p>Abstract</p> <p>Background</p> <p>Recent evidence from developed and developing countries shows clear clinical and public health benefit to starting antiretroviral therapy (ART) earlier. While discussions about when to start ART have often focused on the clinical risks and benefits, the main issue is one of fair limit-setting. We applied a human rights framework to assess a policy of early treatment initiation according to the following criteria: public-health purpose; likely effectiveness; specificity; human rights burdens and benefits; potential for less restrictive approaches; and fair administration.</p> <p>Discussion</p> <p>According to our analysis, a policy of earlier ART initi...
Abstract Background: The human immunodeficiency virus (HIV) epidemic remains a major global public h...
The World Health Organization (WHO) released revised guidelines in 2015 recommending that all people...
More than 3 million people were receiving antiretro-viral therapy (ART) at the end of 2007, but this...
BACKGROUND: Recent evidence from developed and developing countries shows clear clinical and public ...
BACKGROUND: Recent evidence from developed and developing countries shows clear clinical and public ...
Choosing an optimal first line antiret-roviral therapy (ART) in resource-limited settings (RLS) invo...
Introduction: The scale of the HIV pandemic – and the stigma, discrimination and violence that surro...
Recent years have seen significant advances in the science of using antiretroviral medicines (ARVs) ...
Human rights analyses, concepts, and in particular rhetoric have played a consistent role in the glo...
The provision of antiretroviral therapy in resource-limited settings has been one of the most ambiti...
Introduction: Scientific research has demonstrated the clinical benefits of earlier initiation of an...
Increasing attention is being paid to the potential of anti-retroviral treatment (ART) for HIV preve...
Improved prospects for expanded access to antiretroviral therapy (ART) in resource-poor settings are...
A perspective by Chris Kenyon and Robert Colebunders discusses policy implications for use of first ...
Increasing attention is being paid to the potential of anti-retroviral treatment (ART) for HIV preve...
Abstract Background: The human immunodeficiency virus (HIV) epidemic remains a major global public h...
The World Health Organization (WHO) released revised guidelines in 2015 recommending that all people...
More than 3 million people were receiving antiretro-viral therapy (ART) at the end of 2007, but this...
BACKGROUND: Recent evidence from developed and developing countries shows clear clinical and public ...
BACKGROUND: Recent evidence from developed and developing countries shows clear clinical and public ...
Choosing an optimal first line antiret-roviral therapy (ART) in resource-limited settings (RLS) invo...
Introduction: The scale of the HIV pandemic – and the stigma, discrimination and violence that surro...
Recent years have seen significant advances in the science of using antiretroviral medicines (ARVs) ...
Human rights analyses, concepts, and in particular rhetoric have played a consistent role in the glo...
The provision of antiretroviral therapy in resource-limited settings has been one of the most ambiti...
Introduction: Scientific research has demonstrated the clinical benefits of earlier initiation of an...
Increasing attention is being paid to the potential of anti-retroviral treatment (ART) for HIV preve...
Improved prospects for expanded access to antiretroviral therapy (ART) in resource-poor settings are...
A perspective by Chris Kenyon and Robert Colebunders discusses policy implications for use of first ...
Increasing attention is being paid to the potential of anti-retroviral treatment (ART) for HIV preve...
Abstract Background: The human immunodeficiency virus (HIV) epidemic remains a major global public h...
The World Health Organization (WHO) released revised guidelines in 2015 recommending that all people...
More than 3 million people were receiving antiretro-viral therapy (ART) at the end of 2007, but this...